Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Randall J. Bateman(Washington University in St. Louis), Bruno Dubois(Portland State University), Alireza Atri(Banner Sun Health Research Institute), Alan E. Renton(Icahn School of Medicine at Mount Sinai), Richard J. Perrin(Washington University in St. Louis), Monika Baudler(Roche (Switzerland)), Geoffrey A. Kerchner(Roche (Switzerland)), Sarah Berman(University of Pittsburgh Medical Center), David Wallon(Centre Hospitalier Universitaire de Rouen), Luka Kulic(University of Zurich), Christopher H van Dyck(Yale University), Anna Santacruz(Washington University in St. Louis), Paul Delmar(Roche (Switzerland)), Carlos Cruchaga(Washington University in St. Louis), Charlene Supnet(Washington University in St. Louis), Paulo Fontoura(Roche (Switzerland)), William S. Brooks(UNSW Sydney), Raquel Sánchez‐Valle(Biomedical Research Networking Center on Neurodegenerative Diseases), Colin L. Masters(Mental Health Research Institute), Carsten Hofmann(Roche (Switzerland)), Ging‐Yuek Robin Hsiung(University of British Columbia), Jason Hassenstab(Washington University in St. Louis), Suman Jayadev(University of Washington), Jakub Wojtowicz(Roche (Switzerland)), Azad Bonni(Roche (Switzerland)), Rachelle S. Doody(Baylor College of Medicine), Eric McDade(University of Pittsburgh), Catherine J. Mummery(University College London), Douglas Galasko(University of Minnesota), Laura Ibáñez(Washington University in St. Louis), Erik D. Roberson(University of Alabama at Birmingham), Mario Masellis(Sunnybrook Health Science Centre), Andrew J. Aschenbrenner(Washington University in St. Louis), David M. Holtzman(Hope Center for Neurological Disorders), Brian A. Gordon(Mallinckrodt (United States)), Jorge J. Llibre‐Guerra(Washington University in St. Louis), Yan Li(The University of Texas MD Anderson Cancer Center), Susan L. Mills(Washington University in St. Louis), Jérémie Pariente(National Hospital for Neurology and Neurosurgery), Gregory Klein(Roche (Switzerland)), Justin Kinsella(University College Dublin), B. Joy Snider(Washington University in St. Louis), Guoqiao Wang(Washington University in St. Louis), David B. Clifford(Washington University in St. Louis), Tobias Bittner(Roche (Switzerland)), Tammie L.S. Benzinger(Washington University in St. Louis), Chengjie Xiong(Guangzhou Institutes of Biomedicine and Health), Serge Gauthier(Texas Instruments (France))
Cited by 39
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k